Cat: MOF032922W7
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
- Product Details
Specifications
| Host species | Mouse |
| Species Reactivity | SARS-CoV-2 Omicron (B.1.1.529) Nucleocapsid Protein SARS-CoV-2 Nucleocapsid Protein SARS-CoV-2 Nucleocapsid CTD Protein SARS-CoV-2 Nucleocapsid (aa 248-407) Protein SARS-CoV-2 Nucleocapsid (R203K, G204R) Protein SARS-CoV-2 Nucleocapsid (P13L) Protein SARS-CoV-2 Nucleocapsid (D3L, R203K, G204R, S235F) Protein SARS-CoV-2 Nucleocapsid (D3L, S235F) Protein SARS-CoV-2 Nucleocapsid (T205I) Protein SARS-CoV-2 Nucleocapsid (P80R) Protein SARS-CoV-2 Nucleocapsid (A220V) Protein SARS-CoV-2 Nucleocapsid (P199L, M234I) Protein SARS-CoV-2 Nucleocapsid (R203M, D377Y) Protein SARS-CoV-2 Nucleocapsid (A119S, R203K, G204R, M234I) Protein SARS-CoV-2 Nucleocapsid (P67S, P199L) Protein SARS-CoV-2 Nucleocapsid (P13L, T205I, A220V) Protein SARS-CoV-2 Nucleocapsid (P80R, A119S, R203K, G204R, M234I) Protein SARS-CoV-2 Nucleocapsid (P67S, P199L, M234I) Protein SARS-CoV-2 Nucleocapsid (D63G, R203M, D377Y) Protein |
| Specificity | Recognize Omicron Nucleocapsid Protein. |
| Immunogen | SARS-CoV-2 Nucleocapsid CTD Protein |
| Format | Liquid |
| Buffer | PBS |
| Regulatory Status | For Research Use Only. Not For Clinical Use. |
| Shipping | Gel Pack |
| Storage | Store at 4 °C short term. Aliquot and store at -20 °C long term. Avoid freeze-thaw cycles. |
| Purity | > 95% was determined by SDS-PAGE |
| Purification | Protein A |
Application Information
| Application | WB, ELISA |
| Application Notes | WB: 1:500-1:2000 ELISA: 1:1000-1:2000 The optimal dilution should be determined by the end user. |
Target
| Introduction | Omicron multiplies in the bronchi (lung airways) about 70 times faster than the Delta variant, but there is evidence that it is not as severe as previous strains, especially compared to the Delta variant. Omicron may not penetrate deep lung tissue. Omicron infections had a 91% lower fatality rate and a 51% lower risk of hospitalization than the delta variant. However, when reinfection was excluded, the estimated difference in the risk inherent in hospitalization was greatly reduced to 0-30%. Overall, the extremely high transmission rate, combined with its ability to evade dual vaccination and the body's immune system, means that the total number of patients requiring hospitalization at any given time remains a concern. |
| Product Overview | Mouse Anti-Omicron Nucleocapsid Antibody, IgG1 (MOF032922WJ7) is a Mouse antibody against Omicron Nucleocapsid. It can be used for Omicron Nucleocapsid detection in Western Blot, Enzyme-Linked Immunosorbent Assay. |
See other products for " Omicron Nucleocapsid "
For Research Use Only | Not For Clinical Use.